Mentions:
Complexes 1 and 2 were evaluated for their ability to inhibit the growth of BEL-7402, HUH-7, and HepG2 human hepatoma cell lines using MTT assay. The inhibition was expressed as cell viability relative to control without 1 and 2 treatments. In the present study, BEL-7402, HUH-7, and HepG2 human hepatoma cells were used which have been recently characterized as a suitable model for in vitro assessment of hepatoma toxicity [32, 33]. And 5-Fluorouracil (5-FU, 30 μM) was used as a positive control, which has been used extensively as an efficient anticancer drug in clinical trials [32–34]. After treated for 24 h, 48 h, and 72 h on the selected three cell lines, the cells viability is showed in Figures 2, 3, and 4 and the IC50 values is summarized in Table 2.

Mentions:
Complexes 1 and 2 were evaluated for their ability to inhibit the growth of BEL-7402, HUH-7, and HepG2 human hepatoma cell lines using MTT assay. The inhibition was expressed as cell viability relative to control without 1 and 2 treatments. In the present study, BEL-7402, HUH-7, and HepG2 human hepatoma cells were used which have been recently characterized as a suitable model for in vitro assessment of hepatoma toxicity [32, 33]. And 5-Fluorouracil (5-FU, 30 μM) was used as a positive control, which has been used extensively as an efficient anticancer drug in clinical trials [32–34]. After treated for 24 h, 48 h, and 72 h on the selected three cell lines, the cells viability is showed in Figures 2, 3, and 4 and the IC50 values is summarized in Table 2.